The emerging role of complement C3 as a biomarker of insulin resistance and cardiometabolic diseases: preclinical and clinical evidence

F Ursini, L Abenavoli - Reviews on recent clinical trials, 2018 - ingentaconnect.com
Background: An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence

F Ursini, L Abenavoli - Reviews on recent clinical trials, 2018 - pubmed.ncbi.nlm.nih.gov
Background An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence.

F Ursini, L Abenavoli - Reviews on Recent Clinical Trials, 2018 - europepmc.org
BACKGROUND: An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

The emerging role of complement c3 as a biomarker of insulin resistance and cardiometabolic diseases: Preclinical and clinical evidence

F Ursini, L Abenavoli - REVIEWS ON RECENT CLINICAL TRIALS, 2018 - cris.unibo.it
Background: An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

The emerging role of complement c3 as a biomarker of insulin resistance and cardiometabolic diseases: Preclinical and clinical evidence

F Ursini, L Abenavoli - REVIEWS ON RECENT CLINICAL TRIALS, 2018 - sfera.unife.it
Background: An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

[引用][C] The Emerging Role of Complement c3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence.

F Ursini, L Montebianco Abenavoli - REVIEWS ON RECENT …, 2018 - iris.unicz.it
The Emerging Role of Complement c3 as A Biomarker of Insulin Resistance and
Cardiometabolic Diseases: Preclinical and Clinical Evidence. IRIS IRIS Home Sfoglia …